Carregant...
SUN-LB117 Faster Acting Insulin Aspart in Patients With Gestational Diabetes Mellitus - an Early Experience From India
Aims: This study was undertaken to assess the effectiveness and safety of faster acting insulin aspart in patients with gestational diabetes. Though faster acting insulin aspart is approved to be used in pregnancy by regulatory bodies like USFDA, EMA and DCGI (India), no data is published till date...
Guardat en:
| Publicat a: | J Endocr Soc |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7208662/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.2115 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|